StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.75+0.04 (+5.86%)

Close on Nov 17, 2026Market cap $48.11MP/E –Yield –

iBio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

iBio's price to book ratio was 0.5× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.1× to 3.8×, with a median of 0.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×−0.2
2025Dec 31, 20250.7×−0.5
2024Dec 31, 20241.2×+1.0
2023Dec 29, 20230.1×+0.1
2022Dec 30, 20220.1×−1.0
2021Dec 31, 20211.1×−1.3
2020Dec 31, 20202.4×+1.1
2019Oct 31, 20191.3×+0.3
2018Dec 31, 20181.1×−1.6
2017Dec 29, 20172.7×−2.3
2016Dec 30, 20165.0×+0.6
2015Dec 31, 20154.4×−4.1
2014Dec 31, 20148.6×+5.2
2013Dec 31, 20133.4×−3.1
2012Dec 31, 20126.5×−23.9
2011Dec 30, 201130.3×–

More iBio figures

See a number that looks wrong?